Related Experiment Video
Updated: Jan 29, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin
R van den Berg1,2, C L Slim3, Helen L Lutgers1
1Medisch Centrum Leeuwarden, afd. Interne Geneeskunde, Leeuwarden.
Background:
Supraphysiological doses of biotin are being tested in patients with multiple sclerosis. Biotin can cause interference with laboratory assessment of thyroid function, and therefore give a false suggestion of thyrotoxicosis.
Case Description:
A 64-year-old patient was referred for assessment of thyrotoxicosis, due to Graves' disease. Antithyroid medication was started, but there was no effect on laboratory results. In addition, he developed symptoms which subsequently could be attributed to iatrogenic hypothyroidism. Biotin interference, when assaying TSH and thyroxin, was suspected. Upon further investigation, the patient revealed to use high doses of biotin. After discontinuation of the biotin treatment, the thyroid function test normalized.
Conclusion:
It is expected that in the future, patients with multiple sclerosis will use biotin more often. Therefore, it is important for healthcare professionals to be aware that biotin can interfere with immunoassays for thyroid hormones, to avoid misdiagnosis and unnecessary treatment for hyperthyroidism.
Related Concept Videos
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Apparent Weight
Consider a person standing on a bathroom scale inside an elevator. If the scale is accurate at rest, its reading equals the...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

